Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Endothelial Dysfunction in Rheumatoid Arthritis
NCT03085940Completed
- Sponsor
- Universitas Indonesia
- Start
- Jan 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in rheumatoid arthritis (RA) comparing Hydroxychloroquine with Placebo (2 arms). Primary endpoint: Endothelial dysfunction marker at 3 months. Started Jan 2017; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03085940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03085940.